Product Program year 2023 Source: CMS Open Payments

Gliadel

Drug Neurology

NDC 24338-050-08

Open in the dashboard

General payments

$29,244

1,133 payments

Research payments

$302,809

119 payments

Through program year 2023, $29,244 in general payments and $302,809 in research payments were reported against Gliadel (Neurology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Amount Payments
2023 General $5,161 275
2023 Research $80,926 31
2022 General $8,355 274
2022 Research $129,070 52
2021 General $12,796 411
2021 Research $92,813 36
2020 General $2,933 173

Breakdown

Who paid General payments · program years 2020–2023
  1. Arbor Pharmaceuticals, Inc. $23,282 810 payments
  2. CutisPharma, Inc. $5,961 323 payments
Top recipients General payments · program year 2023
  1. Daniel Fahim Neurological Surgery · Royal Oak, MI $186 4% · 9 payments
  2. Michael Schaeffer Physician Assistant, Surgical · New Hudson, MI $162 3% · 8 payments
  3. Karol Zakalik Neurological Surgery · Royal Oak, MI $90 2% · 5 payments
  4. Clifford Soults Neurological Surgery · Syracuse, NY $85 2% · 4 payments
  5. Corrie Burgess Nurse Practitioner, Family · Syracuse, NY $85 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2023
  1. Neurological Surgery $1,712 33% · 60 practitioners
  2. Nurse Practitioner, Family Nurse Practitioner $631 12% · 23 practitioners
  3. Physician Assistant $482 9% · 17 practitioners
  4. Physician Assistant, Surgical Physician Assistant $449 9% · 13 practitioners
  5. Radiation Oncology Radiology $248 5% · 5 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2023
  1. Michigan $975 19% · 18 recipients
  2. New York $724 14% · 23 recipients
  3. Kentucky $525 10% · 15 recipients
  4. Alabama $409 8% · 19 recipients
  5. Mississippi $390 8% · 17 recipients

The top 5 of 28 states; each share is of general payments naming this product in 2023 where a state was reported.

The top 25 states, free in the app

1,133 general · 119 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record